Your browser doesn't support javascript.
loading
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial).
Ruddy, Kathryn J; Zheng, Yue; Tayob, Nabihah; Hu, Jiani; Dang, Chau T; Yardley, Denise A; Isakoff, Steven J; Valero, Vicente V; Faggen, Meredith G; Mulvey, Therese M; Bose, Ron; Sella, Tal; Weckstein, Douglas J; Wolff, Antonio C; Reeder-Hayes, Katherine E; Rugo, Hope S; Ramaswamy, Bhuvaneswari; Zuckerman, Dan S; Hart, Lowell L; Gadi, Vijayakrishna K; Constantine, Michael; Cheng, Kit L; Briccetti, Frederick M; Schneider, Bryan P; Merrill Garrett, A; Kelly Marcom, P; Albain, Kathy S; DeFusco, Patricia A; Tung, Nadine M; Ardman, Blair M; Nanda, Rita; Jankowitz, Rachel C; Rimawi, Mothaffar; Abramson, Vandana; Pohlmann, Paula R; Van Poznak, Catherine; Forero-Torres, Andres; Liu, Minetta C; Rosenberg, Shoshana; DeMeo, Michelle K; Burstein, Harold J; Winer, Eric P; Krop, Ian E; Partridge, Ann H; Tolaney, Sara M.
Afiliação
  • Ruddy KJ; Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. ruddy.kathryn@mayo.edu.
  • Zheng Y; Dana-Farber Cancer Institute, Boston, USA.
  • Tayob N; Dana-Farber Cancer Institute, Boston, USA.
  • Hu J; Dana-Farber Cancer Institute, Boston, USA.
  • Dang CT; Memorial Sloan Kettering Cancer Center, New York, USA.
  • Yardley DA; Tennessee Oncology, Nashville, USA.
  • Isakoff SJ; Massachussetts General Hospital, Boston, USA.
  • Valero VV; MD Anderson Cancer Center, Houston, USA.
  • Faggen MG; Dana-Farber Cancer Institute, Boston, USA.
  • Mulvey TM; Massachussetts General Hospital, Boston, USA.
  • Bose R; Siteman Cancer Center, St. Louis, USA.
  • Sella T; Dana-Farber Cancer Institute, Boston, USA.
  • Weckstein DJ; New Hampshire Oncology and Hematology, Hooksett, USA.
  • Wolff AC; Johns Hopkins University, Baltimore, USA.
  • Reeder-Hayes KE; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, USA.
  • Rugo HS; Diller Family Comprehensive Cancer Center, University of California San Francisco Helen, San Francisco, USA.
  • Ramaswamy B; Ohio State University Comprehensive Cancer Center, Columbus, USA.
  • Zuckerman DS; St. Luke's Mountain States Tumor Institute, Boise, USA.
  • Hart LL; Florida Cancer Specialists, Brandon, USA.
  • Gadi VK; University of Illinois At Chicago, Chicago, USA.
  • Constantine M; Dana-Farber Cancer Institute, Boston, USA.
  • Cheng KL; Northwell Health, New York, USA.
  • Briccetti FM; Dana-Farber Cancer Institute, Boston, USA.
  • Schneider BP; Indiana University School of Medicine, Indianapolis, USA.
  • Merrill Garrett A; Eastern Maine Medical Center, Bangor, USA.
  • Kelly Marcom P; Duke University, Durham, USA.
  • Albain KS; Loyola University Medical Center, Maywood, USA.
  • DeFusco PA; Hartford HealthCare Cancer Institute, Avon, USA.
  • Tung NM; Beth Israel Deaconess Medical Center, Boston, USA.
  • Ardman BM; Lowell General Hospital, Lowell, USA.
  • Nanda R; University of Chicago, Chicago, USA.
  • Jankowitz RC; Penn Medicine Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Rimawi M; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
  • Abramson V; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
  • Pohlmann PR; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
  • Van Poznak C; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.
  • Forero-Torres A; Kirklin UAB Hematology Oncology, Birmingham, AL, USA.
  • Liu MC; Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
  • Rosenberg S; Dana-Farber Cancer Institute, Boston, USA.
  • DeMeo MK; Dana-Farber Cancer Institute, Boston, USA.
  • Burstein HJ; Dana-Farber Cancer Institute, Boston, USA.
  • Winer EP; Dana-Farber Cancer Institute, Boston, USA.
  • Krop IE; Dana-Farber Cancer Institute, Boston, USA.
  • Partridge AH; Dana-Farber Cancer Institute, Boston, USA.
  • Tolaney SM; Dana-Farber Cancer Institute, Boston, USA.
Breast Cancer Res Treat ; 189(1): 103-110, 2021 Aug.
Article em En | MEDLINE | ID: mdl-34120223
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Maitansina Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Maitansina Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article